Nicholas Tymoczko is an associate in the Intellectual Property practice of Paul Hastings and is based in the firm’s New York office. His practice focuses on complex patent litigation, primarily in the pharmaceutical and biotechnology fields. Prior to joining Paul Hastings, Mr. Tymoczko was an associate at another multinational law firm.
Mr. Tymoczko received his J.D. from the University of Minnesota Law School, magna cum laude, Order of the Coif, where he served as a Managing Editor of the Minnesota Law Review. He received a B.A. in Philosophy with general honors from the University of Chicago. Mr. Tymoczko is a member of the New York State Bar and is admitted to practice in the United States District Courts for the Southern and Eastern Districts of New York.
Reading the Tea Leaves from the TC Heartland LLC v. Kraft Food Group Brands LLC Oral Argument
March 30, 2017
Federal Circuit Issues Expansive Ruling in Upholding Jurisdiction over Mylan in Delaware
March 18, 2016
In an Issue of First Impression, the Federal Circuit Finds Infringement as a Matter of Law Despite a Sworn Certification Promising No Infringement
September 26, 2013
Recognized at the 2016 LMG Life Sciences Awards
Paul Hastings was recognized with multiple LMG Life Sciences Awards. Bruce Wexler was named “General Patent Litigator of the Year – New York” and Naveen Modi was recognized as Post Grant Proceedings Attorney of the Year. The Life Sciences Patent Litigation practice also won awards for two Hatch-Waxman Impact Cases of the Year, including Helsinn Healthcare SA v. Teva Pharmaceuticals USA, a win resolving a long-running patent dispute over Aloxi®, a drug used to treat chemotherapy-induced nausea and vomiting.
The Paul Hastings team representing Helsinn was led by Joseph O’Malley. The firm was also honored for its work on behalf of Eli Lily in Sanofi-Aventis US v. Eli Lilly & Co., where Bruce Wexler led the team representing Eli Lily in litigation regarding the marketing of Basaglar®, its insulin glargine drug product. The case was settled in late 2015, with the press reporting Eli Lilly’s ability to launch the drug.
September 16, 2016
Shortlisted for four LMG Life Sciences Awards for 2016
The Firm was shortlisted in four categories for the LMG Life Sciences Awards. Joseph O’Malley was nominated in the Hatch-Waxman Litigator of the Year – Branded category, Bruce Wexler was nominated in the General Patent Litigator of the Year - New Yorkcategory, Naveen Modi was nominated in the Post Grant Proceedings Attorney of the Year category, and the Firm was nominated in the “Hatch-Waxman Litigation Firm of the Year – Branded” category.
July 27, 2016
Nominated for the Legal Media Group's LMG Life Science Awards
The firm was nominated for the Legal Media Group's 2013 LMG Life Sciences awards in the categories of “Litigation Team of the Year” and “(General) Patent Litigation: Firm of the Year."
August 12, 2013